Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070]

Patricia Monzó-Gallo¹, Carlos Lopera¹, Ana M Badía-Tejero², Marina Machado³, Julio García-Rodríguez⁴, Pablo Vidal-Cortés⁵, Esperanza Merino⁶, Jorge Calderón⁷, Jesús Fortún⁸, Zaira R Palacios-Baena⁹, Javier Pemán¹⁰, Joan Roig Sanchis¹¹, Manuela Aguilar-Guisado¹², Carlota Gudiol¹³, Juan C Ramos⁴, Isabel Sánchez-Romero⁷, Pilar Martin-Davila⁸, Luis E López-Cortés⁹, Miguel Salavert¹⁰, Isabel Ruiz-Camps¹¹, Mariana Chumbita¹, Tommaso Francesco Aiello¹, Olivier Peyrony¹⁴, Pedro Puerta-Alcalde¹⁵, Alex Soriano¹⁶, Francesc Marco¹⁷, Carolina Garcia-Vidal¹⁸

Affiliations

¹ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain.
² Department of Infectious Diseases, Hospital of Bellvitge, Barcelona, Spain.
³ Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid - Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
⁴ Infectious Diseases Unit, University Hospital La Paz, Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
⁵ Intensive Care Unit, University Hospital of Ourense, Ourense, Spain.
⁶ Department of Infectious Diseases, Hospital General Universitario Dr. Balmis -Instituto, Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
⁷ Department of Infectious Diseases, University Hospital Puerta de Hierro, Madrid, Spain.
⁸ Department of Infectious Diseases, University Hospital Ramon y Cajal, Madrid, Spain.
⁹ Infectious Diseases and Microbiology Clinical Unit, University Hospital Virgen Macarena, Institute of Biomedicine of Seville (IBiS) and CSIC, Seville, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
¹⁰ Infectious Diseases Unit (Medical Clinical Department), University and Polytechnic Hospital La Fe, La Fe Health Research Institute (IIS-La Fe), Valencia, Spain.
¹¹ Department of Infectious Diseases, University Hospital Vall d'Hebron, Barcelona, Spain.
¹² Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
¹³ Department of Infectious Diseases, Hospital of Bellvitge, Barcelona, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
¹⁴ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; Emergency Department, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
¹⁵ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
¹⁶ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
¹⁷ Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain; Department of Microbiology, Hospital Clinic of Barcelona, Barcelona, Spain.
¹⁸ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain. Electronic address: cgarciav@clinic.cat.

PMID: 39067149
DOI: 10.1016/j.ijid.2024.107188

Free article

Published Erratum

Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070]

Patricia Monzó-Gallo et al. Int J Infect Dis. 2024 Sep.

Free article

. 2024 Sep:146:107188.

doi: 10.1016/j.ijid.2024.107188. Epub 2024 Jul 26.

Authors

Affiliations

¹ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain.
² Department of Infectious Diseases, Hospital of Bellvitge, Barcelona, Spain.
³ Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid - Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
⁴ Infectious Diseases Unit, University Hospital La Paz, Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
⁵ Intensive Care Unit, University Hospital of Ourense, Ourense, Spain.
⁶ Department of Infectious Diseases, Hospital General Universitario Dr. Balmis -Instituto, Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
⁷ Department of Infectious Diseases, University Hospital Puerta de Hierro, Madrid, Spain.
⁸ Department of Infectious Diseases, University Hospital Ramon y Cajal, Madrid, Spain.
⁹ Infectious Diseases and Microbiology Clinical Unit, University Hospital Virgen Macarena, Institute of Biomedicine of Seville (IBiS) and CSIC, Seville, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
¹⁰ Infectious Diseases Unit (Medical Clinical Department), University and Polytechnic Hospital La Fe, La Fe Health Research Institute (IIS-La Fe), Valencia, Spain.
¹¹ Department of Infectious Diseases, University Hospital Vall d'Hebron, Barcelona, Spain.
¹² Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
¹³ Department of Infectious Diseases, Hospital of Bellvitge, Barcelona, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
¹⁴ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; Emergency Department, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
¹⁵ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
¹⁶ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain.
¹⁷ Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain; Department of Microbiology, Hospital Clinic of Barcelona, Barcelona, Spain.
¹⁸ Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain. Electronic address: cgarciav@clinic.cat.

PMID: 39067149
DOI: 10.1016/j.ijid.2024.107188

No abstract available

PubMed Disclaimer

Erratum for

Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.
Monzó-Gallo P, Lopera C, Badía-Tejero AM, Machado M, García-Rodríguez J, Vidal-Cortés P, Merino E, Calderón J, Fortún J, Palacios-Baena ZR, Pemán J, Sanchis JR, Aguilar-Guisado M, Gudiol C, Ramos JC, Sánchez-Romero I, Martin-Davila P, López-Cortés LE, Salavert M, Ruiz-Camps I, Chumbita M, Aiello TF, Peyrony O, Puerta-Alcalde P, Soriano A, Marco F, Garcia-Vidal C. Monzó-Gallo P, et al. Int J Infect Dis. 2024 Jul;144:107070. doi: 10.1016/j.ijid.2024.107070. Epub 2024 Apr 23. Int J Infect Dis. 2024. PMID: 38663477

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070]

Affiliations

Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous